PPAR-Gamma Pro12Ala Polymorphism and Gastric Cancer Risk in a Turkish Population

Canbay, Emel; Kurnaz, Ozlem; Canbay, Bahar; Bugra, Dursun; Cakmakoglu, Bedia; Bulut, Turker; Yamaner, Sumer; Sokucu, Necmettin; Buyukuncu, Yilmaz; Yilmaz-Aydogan, Hulya

추천

검색

자료유형: 학술저널

저자정보: Canbay, Emel (National Peritoneal Organization to support Peritoneal Dissemination Treatment, Tokushukai Hospital) Kurnaz, Ozlem (Istanbul University, Experimental Medicine and Research Institute [DETAE], Department of Molecular Medicine) Canbay, Bahar (Cerrahpasa Medical Faculty, Istanbul University) Bugra, Dursun (American Hospital, General Surgery Clinic) Cakmakoglu, Bedia (Istanbul University, Experimental Medicine and Research Institute [DETAE], Department of Molecular Medicine) Bulut, Turker (Istanbul University, Istanbul Medical Faculty, Department of General Surgery) Yamaner, Sumer (Istanbul University, Istanbul Medical Faculty, Department of General Surgery) Sokucu, Necmettin (Istanbul University, Istanbul Medical Faculty, Department of General Surgery) Buyukuncu, Yilmaz (Istanbul University, Istanbul Medical Faculty, Department of General Surgery) Yilmaz-Aydogan, Hulya (Istanbul University, Experimental Medicine and Research Institute [DETAE], Department of Molecular Medicine)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제13권 제11호

발행연도: 2012.1

수록면: 5,875 - 5,878 (4page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: Peroxisome proliferator-activated receptor gamma ($PPAR{\gamma}$) is a ligand dependent transcription factor involved in various processes, including carcinogenesis. We aimed to investigate any possible association of the $PPAR{\gamma}$ Pro12Ala (rs1801282) polymorphism with risk of developing gastric cancer (GC). Patients and Methods: A hospital based case control study was designed covering 50 patients with GC and 120 healthy controls. The frequencies of $PPAR{\gamma}$ Pro12Ala (rs1801282) were determined using a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay. Results: The Ala12 allele of the $PPAR{\gamma}$ Pro12Ala G gene was associated with a 1.95 fold increased risk of GC development (p: 0.022; 95% CI: 1.58-2.40). Subgroup analyses showed that the same allele was also associated with metastasis (p: 0.000; OR:4.09; 95%CI:2.273-7.368) and differentiation (p: 0.004; OR:1.95; 95%CI:1.335-2.875) in patients with GC. Conclusion: This study suggests that the $PPAR{\gamma}$ Pro12Ala G (Ala12) allele might be associated with development, differentiation and metastatic process of GC in the Turkish population. Further studies conducted in larger study groups and in different ethnic populations will be needed to clarify the exact role of the $PPAR{\gamma}$ Pro12Ala polymorphism in GC.

#$PPAR{gamma}$ Pro12Ala polymorphism #gastric cancer #Turkish population

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요